China International Capital Corporation Limited

SEHK:3908 Stok Raporu

Piyasa değeri: HK$138.4b

China International Capital Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

China International Capital şirketinin kazançları yıllık ortalama -1% oranında azalırken, Capital Markets sektörünün kazançları yıllık 3.2% oranında artan oldu. Gelirler yıllık ortalama 2.6% oranında artan oldu. China International Capital şirketinin öz sermaye getirisi 4% olup, net marjı 17.6% dir.

Anahtar bilgiler

-1.0%

Kazanç büyüme oranı

-3.6%

EPS büyüme oranı

Capital Markets Sektör Büyümesi-6.0%
Gelir büyüme oranı2.6%
Özkaynak getirisi4.0%
Net Marj17.6%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

China International Capital Corporation Limited's (HKG:3908) 66% Jump Shows Its Popularity With Investors

Sep 30
China International Capital Corporation Limited's (HKG:3908) 66% Jump Shows Its Popularity With Investors

Many Still Looking Away From China International Capital Corporation Limited (HKG:3908)

Jun 18
Many Still Looking Away From China International Capital Corporation Limited (HKG:3908)

China International Capital Corporation Limited (HKG:3908) Analysts Just Slashed This Year's Revenue Estimates By 12%

May 10
China International Capital Corporation Limited (HKG:3908) Analysts Just Slashed This Year's Revenue Estimates By 12%

Potential Upside For China International Capital Corporation Limited (HKG:3908) Not Without Risk

Dec 18
Potential Upside For China International Capital Corporation Limited (HKG:3908) Not Without Risk

China International Capital Corporation Limited (HKG:3908) Analysts Are More Bearish Than They Used To Be

Sep 01
China International Capital Corporation Limited (HKG:3908) Analysts Are More Bearish Than They Used To Be

Here's Why I Think China International Capital (HKG:3908) Is An Interesting Stock

Jun 01
Here's Why I Think China International Capital (HKG:3908) Is An Interesting Stock

China International Capital Corporation Limited (HKG:3908) Analysts Just Trimmed Their Revenue Forecasts By 15%

May 05
China International Capital Corporation Limited (HKG:3908) Analysts Just Trimmed Their Revenue Forecasts By 15%

Here's Why I Think China International Capital (HKG:3908) Might Deserve Your Attention Today

Feb 22
Here's Why I Think China International Capital (HKG:3908) Might Deserve Your Attention Today

Here's Why I Think China International Capital (HKG:3908) Might Deserve Your Attention Today

Nov 21
Here's Why I Think China International Capital (HKG:3908) Might Deserve Your Attention Today

Here's Why We Think China International Capital (HKG:3908) Is Well Worth Watching

Aug 08
Here's Why We Think China International Capital (HKG:3908) Is Well Worth Watching

Time To Worry? Analysts Just Downgraded Their China International Capital Corporation Limited (HKG:3908) Outlook

May 11
Time To Worry? Analysts Just Downgraded Their China International Capital Corporation Limited (HKG:3908) Outlook

Here's Why I Think China International Capital (HKG:3908) Might Deserve Your Attention Today

May 10
Here's Why I Think China International Capital (HKG:3908) Might Deserve Your Attention Today

China International Capital Corporation Limited (HKG:3908) Is An Attractive Dividend Stock - Here's Why

Mar 16
China International Capital Corporation Limited (HKG:3908) Is An Attractive Dividend Stock - Here's Why

China International Capital (HKG:3908) Shareholders Booked A 72% Gain In The Last Five Years

Feb 26
China International Capital (HKG:3908) Shareholders Booked A 72% Gain In The Last Five Years

Should You Take Comfort From Insider Transactions At China International Capital Corporation Limited (HKG:3908)?

Jan 22
Should You Take Comfort From Insider Transactions At China International Capital Corporation Limited (HKG:3908)?

Gelir ve Gider Dağılımı

China International Capital nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SEHK:3908 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2421,2943,74611,8040
30 Jun 2420,6894,16210,1630
31 Mar 2420,2734,47711,8420
31 Dec 2323,0515,49611,7940
30 Sep 2324,8795,64112,9370
30 Jun 2325,8996,69313,2740
31 Mar 2328,7077,64213,0100
31 Dec 2227,6487,04512,9680
30 Sep 2229,0378,98214,6100
30 Jun 2231,3269,16119,6620
31 Mar 2232,32410,20814,2070
31 Dec 2133,19410,42314,2920
30 Sep 2132,1679,66711,7390
30 Jun 2132,3338,92412,2530
31 Mar 2129,1957,70412,0820
31 Dec 2027,7047,10512,2020
30 Sep 2023,8465,9348,2450
30 Jun 2019,9035,3308,5230
31 Mar 2017,6004,5508,3070
31 Dec 1916,5964,1828,1040
30 Sep 1913,8523,8547,0160
30 Jun 1913,7593,7133,8830
31 Mar 1913,7383,6327,0120
31 Dec 1813,0783,4357,0090
30 Sep 1814,0733,4776,4490
30 Jun 1813,6703,2297,1040
31 Mar 1813,2293,0216,3630
31 Dec 1712,0032,7096,4240
30 Sep 1710,7712,5974,2980
30 Jun 179,5992,2995,3510
31 Mar 177,8411,8903,6070
31 Dec 167,5451,7634,2980
30 Sep 166,4211,5131,1340
30 Jun 166,5791,3343,6510
31 Mar 167,4821,6274,1250
31 Dec 158,3841,9194,5990
30 Sep 158,0601,9014,4160
30 Jun 157,7371,8824,2320
31 Mar 156,5621,5003,6600
31 Dec 145,3861,1183,0890
30 Sep 144,6968344,3030
30 Jun 143,8875493,3560
31 Mar 143,6354602,7620
31 Dec 133,3823702,1680

Kaliteli Kazançlar: 3908 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 3908 'nin mevcut net kar marjları (17.6%) geçen yılın (22.7%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 3908 şirketinin kazançları son 5 yılda yılda 1% oranında azaldı.

Büyüme Hızlandırma: 3908 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: 3908 geçtiğimiz yıl negatif kazanç büyümesine ( -33.6% ) sahipti ve bu da onu Capital Markets sektör ortalamasıyla ( -50% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: 3908 'nin Özsermaye Getirisi ( 4% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin